1Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747.
2Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:t-herapeutic options[J].Lancet Oncol,2007,8(3):235.
3Sorlie T,Perou CM,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications ative breast cancer:therapeutic options[J].Proc Natl Acad Sci USA,2001,98(19):10869.
4Livasy CA,Karaca G,Nanda R,et al.Phenotypic evaluation of the Basal-like Subtype of invasive breast carcinoma[J].Mod Pathol,2006,19(2):264.
5Reis-Filho JS,Milanezi F,Steele D,et al.Metaplastic breast carcinomas are Basal-like tumours[J].Histopathology,2006,49(1):10.
6Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25.
7Turner N,Tutt A,Ashworth A.Hallmarks of ‘BRCAness' in sporadic cancers[J].Nat Rev Cancer,2004,4(10):814.
8Millikan RC,Newman B,Tse C-K,et al.Epidemiology of basal-like breast cancer[J].Breast Cancer Res Treat,2008,109(1):123.
9Malzahn K,Mitze M,Thoenes M,et al.Biological and Prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas[J].Virchows Arch,1998,433(2):119.
10Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].J Clin Oncol,2006,24(14):2137.
4Sφrlie T,Perou CM,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinicalimplications[J].Proc Natl Acad Sci USA,2001,98(19):10869-10874.
5Aksoy S,Dizdar O,Harputluoglu H,et al.Demographic,clinical,and pathological characteristics of Turkish triple-negative breast cancer patients:single center experience[J].Ann Oncol,2007,18(11):1904-1906.
6Baker EA,Stephenson TJ,Reed MW,et al.Expression of proteinases and inhibitors in human breast cancer progression and survival[J].Mol Pathol,2002,55(5):300-304.
7Sauter ER,Nesbit M,Watson JC,et al.Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck[J].Clin Cancer Res,1999,5(4):775-782.
8Adams J,Carder PJ,Downey S,et al.Vascular endothelial growth factor (VEGF) in breast cancer:comparison of plasma,serum,and tissue VEGF and microvessel density and effects of tamoxifen[J].Cancer Res,2000,60(11):2898-2905.
9Shimizu M,Saitoh Y,Itoh H.Immunohistochemical staining of Ha-ras oncogene product in normal,benign,and malignant human pancreatic tissues[J].Cancer Res,1990,21(6):607-612.
10Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clin Cancer Res,2004,10(16):5367-5374.
